Balance Labs, Inc. (BLNC)
- Previous Close
0.1830 - Open
0.1830 - Bid 0.1840 x --
- Ask 0.2880 x --
- Day's Range
0.1830 - 0.1830 - 52 Week Range
0.1820 - 0.4000 - Volume
4,500 - Avg. Volume
77 - Market Cap (intraday)
3.966M - Beta (5Y Monthly) -0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date May 19, 2025 - May 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company offers services that help businesses in various industries improve and fine-tune their business models, sales and marketing plans, and internal operations, as well as make introductions to professional services, such as business plan writing, accounting firms, and legal service providers. The company also assists in the development and execution of various services, such as business model development, including marketing research, naming, and branding; plan writing; financial modeling; website and mobile app development; employee and board member recruitment; patent/trademark filing assistance; product or service development; product production; marketing material development; product or service placement; celebrity endorsements; and introductions to professional services, such as legal and accounting. Balance Labs, Inc. was incorporated in 2014 and is headquartered in Miami Beach, Florida. Balance Labs, Inc. is a subsidiary of Balance Holdings, LLC.
www.balancelabs.coRecent News: BLNC
View MorePerformance Overview: BLNC
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BLNC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BLNC
View MoreValuation Measures
Market Cap
3.97M
Enterprise Value
6.41M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-107.21%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-528.22k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
95.58k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
31.4k